+++
title = "Gender as a Modifying Factor Influencing Myotonic Dystrophy Type 1 Phenotype Severity and Mortality: A Nationwide Multiple Databases Cross-Sectional Observational Study."
date = "2016-01-01"
authors = ["Dogan Celine", "De Antonio Marie", "Hamroun Dalil", "Varet Hugo", "Fabbro Marianne", "Rougier Felix", "Amarof Khadija", "Arne Bes Marie-Christine", "Bedat-Millet Anne-Laure", "Behin Anthony", "Bellance Remi", "Bouhour Francoise", "Boutte Celia", "Boyer Francois", "Campana-Salort Emmanuelle", "Chapon Francoise", "Cintas Pascal", "Desnuelle Claude", "Deschamps Romain", "Drouin-Garraud Valerie", "Ferrer Xavier", "Gervais-Bernard Helene", "Ghorab Karima", "Laforet Pascal", "Magot Armelle", "Magy Laurent", "Menard Dominique", "Minot Marie-Christine", "Nadaj-Pakleza Aleksandra", "Pellieux Sybille", "Pereon Yann", "Preudhomme Marguerite", "Pouget Jean", "Sacconi Sabrina", "Sole Guilhem", "Stojkovich Tanya", "Tiffreau Vincent", "Urtizberea Andoni", "Vial Christophe", "Zagnoli Fabien", "Caranhac Gilbert", "Bourlier Claude", "Riviere Gerard", "Geille Alain", "Gherardi Romain K", "Eymard Bruno", "Puymirat Jack", "Katsahian Sandrine", "Bassez Guillaume"]
publication_types = ["2"]
publication = "PloS one, https://doi.org/10.1371/journal.pone.0148264"
publication_short = "PloS one, https://doi.org/10.1371/journal.pone.0148264"
abstract = "BACKGROUND:Myotonic Dystrophy type 1 (DM1) is one of the most heterogeneous hereditary disease in terms of age of onset, clinical manifestations, and severity, challenging both medical management and clinical trials. The CTG expansion size is the main factor determining the age of onset although no factor can finely predict phenotype and prognosis. Differences between males and females have not been specifically reported. Our aim is to study gender impact on DM1 phenotype and severity.METHODS:We first performed cross-sectional analysis of main multiorgan clinical parameters in 1409 adult DM1 patients (&gt;18 y) from the DM-Scope nationwide registry and observed different patterns in males and females. Then, we assessed gender impact on social and economic domains using the AFM-Téléthon DM1 survey (n = 970), and morbidity and mortality using the French National Health Service Database (n = 3301).RESULTS:Men more frequently had (1) severe muscular disability with marked myotonia, muscle weakness, cardiac, and respiratory involvement; (2) developmental abnormalities with facial dysmorphism and cognitive impairment inferred from low educational levels and work in specialized environments; and (3) lonely life. Alternatively, women more frequently had cataracts, dysphagia, digestive tract dysfunction, incontinence, thyroid disorder and obesity. Most differences were out of proportion to those observed in the general population. Compared to women, males were more affected in their social and economic life. In addition, they were more frequently hospitalized for cardiac problems, and had a higher mortality rate.CONCLUSIONS:Gender is a previously unrecognized factor influencing DM1 clinical profile and severity of the disease, with worse socio-economic consequences of the disease and higher morbidity and mortality in males. Gender should be considered in the design of both stratified medical management and clinical trials. "
abstract_short = ""
image_preview = ""
selected = false
projects = []
tags = []
url_pdf = ""
url_preprint = ""
url_code = ""
url_dataset = ""
url_project = ""
url_slides = ""
url_video = ""
url_poster = ""
url_source = ""
math = true
highlight = true
[header]
image = ""
caption = ""
+++
<a href="https://www.scimagojr.com/journalsearch.php?q=10600153309&amp;tip=sid&amp;exact=no" title="SCImago Journal &amp; Country Rank"><img border="0" src="https://www.scimagojr.com/journal_img.php?id=10600153309" alt="SCImago Journal &amp; Country Rank"  /></a>
**SCImago Journal Rank (SJR)** est un indicateur de notoriété des revues indexées à partir de 1996 dans la base de données Scopus de l’éditeur Elsevier. Le SJR a été créé par le groupe de travail SCImago Research Group (SRG) de l’Université de Grenade et Alcana de Henares en Espagne.  
  
Le SJR d’une revue est le nombre de fois où un article de cette revue est cité par d’autres articles pendant les 3 ans qui suivent sa publication, chaque citation reçue étant pondérée par la notoriété de la revue citante. Les articles « citants » sont issus d’autres revues et de la revue notée. Les citations d’articles de la revue par des articles de cette même revue (on parle d’autocitations) sont ainsi incluses dans le calcul du SJR, mais dans une limite de 35 %. Dans le calcul du SJR, le nombre de citations reçues par une revue est rapporté au nombre d’articles publiés par la revue au cours des 3 années qui précèdent.  
  
L'ensemble des revues a été classé en fonction de leur SJR et divisé en quatre groupes égaux, quartiles. Q1 (vert) comprend le quart des journaux avec les valeurs les plus élevées, Q2 (jaune) les deuxièmes valeurs les plus élevées, Q3 (orange) les troisièmes valeurs les plus élevées et Q4 (rouge) les valeurs les plus faibles.  
  
Différent entre le **SJR** et l'**Impact Factor** :  
- Le SJR est calculé pour une période de citation de 3 ans. Il tient compte de la notoriété des revues citantes. Il inclut de façon limitée les autocitations d’une revue ;  
- L'Impact Factor est calculé pour une période de citation de 2 ans. Il ne tient pas compte de la notoriété des revues citantes. Il inclut toutes les autocitations d’une revue.
